References
Roger C, Roberts JA, Muller L (2018) Clinical pharmacokinetics and pharmacodynamics of oxazolidinones. Clin Pharmacokinet 57(5):559–575
Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ (2006) Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Clin Infect Dis 42(5):597–607
Nedved AN, DeFrates SR, Hladnik LM, Stockerl-Goldstein KE (2016) Effect of linezolid on hematologic recovery in newly diagnosed acute myeloid leukemia patients following induction chemotherapy. Pharmacotherapy 36(10):1087–1094
Zhou D, Shi T, Zhao S, Zhu J, Zhu L, Yang X, Xie W, Ye X (2020) Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy. J Clin Pharm Ther 45(4):755–758
Cohen N, Mihu CN, Seo SK, Chung D, Chou J, Heller G, Papanicolaou GA (2009) Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 15(10):1337–1341
Waki F, Ohnishi H, Shintani T, Uemura M, Matsumoto K, Fukumoto T, Kitanaka A, Kubota Y, Tanaka T, Ishida T, Matsunaga T (2012) Linezolid-induced pure red cell aplasia in a patient with Staphylococcus epidermidis infection after allogeneic stem cell transplantation. Transpl Infect Dis 14(4):E1-6
Hu W, Shi B, Liu L, He S, Ye L, Tian D, Zhang Y (2016) Linezolid induced twice pure red cell aplasia in a patient with central nervous system infection after allogeneic stem cell transplantation. Iran J Pharm Res 15(2):647–651
Ballen KK, Gluckman E, Broxmeyer HE (2013) Umbilical cord blood transplantation: the first 25 years and beyond. Blood 122(4):491–498
Konuma T, Kato S, Oiwa-Monna M, Tanoue S, Ogawa M, Isobe M, Tojo A, Takahashi S (2017) Cryopreserved CD34+ cell dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients. Biol Blood Marrow Transplant 23(7):1142–1150
Acknowledgements
The authors thank all of the physicians and staff at the hospital and the cord blood banks in this study.
Author information
Authors and Affiliations
Contributions
T.Y. and T.K. designed the research, analyzed the data, performed the statistical analysis, and wrote the manuscript. Y.N. contributed to the critical review of the manuscript. All the other authors contributed to data collection. All authors approved the final version.
This study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. The institutional review board of the Institute of Medical Science, The University of Tokyo has approved this retrospective study (30–85-B0304).
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yasu, T., Konuma, T., Oiwa-Monna, M. et al. Hematological effects on peri-transplant use of linezolid in adults undergoing single-unit cord blood transplantation. Ann Hematol 100, 2867–2869 (2021). https://doi.org/10.1007/s00277-021-04597-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-021-04597-7